ALX Oncology Holdings Inc. (ALXO)
$1.26+0.80%Close
SELLCRISIS · day 19
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $170M
- Beta
- 0.40
- P/E (TTM)
- -0.98
- Short % float
- 5.30%
- Days to cover
- 3.8
- SI change
- -9.6%
- 1W
- +4.13%
- 1M
- -35.05%
- vs SPY 1W
- +3.71%
- vs SPY 1M
- -37.11%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ALXO?
- LOPJLB’s latest quantitative signal on ALX Oncology Holdings Inc. (ALXO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ALXO in?
- ALX Oncology Holdings Inc. (ALXO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does ALX Oncology Holdings Inc. (ALXO) do?
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The companyâs lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer. It has colla…